Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-21

Clinical Trial Update: NESBID: Neuro-Stimulation of the Brain in Depression [NA]

View source ↗

Summary

NESBID, a trial of neuro-stimulation for depression, has been withdrawn. The study involved transcranial direct current stimulation for major depressive disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant | NA | Status: WITHDRAWN